Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Publicado
Effect of neural therapy on NGF and BDNF serum levels in patients with chronic pain. A pilot study
Efecto de la terapia neural sobre los niveles séricos del NGF y el BDNF en pacientes con dolor crónico. Estudio piloto
Palabras clave:
Nerve Growth Factors, Quality of life, Pain Management, Local Anesthetics, Pain (en)Calidad de vida, Dolor, Factores de crecimiento nervioso, Manejo del dolor, Anestésicos locales (es)
Descargas
Introduction: Neurotrophins (NT) are a family of proteins consisting of the nerve growth factor (NGF), the brain-derived neurotrophic factor (BDNF) and NT-3 and NT-4/5. These proteins play an essential role in neuronal survival, differentiation, and proliferation.
Objectives: To analyze the variations of NGF and BDNF serum levels in patients with chronic pain after undergoing neural therapy and to establish the effects of this type of intervention on their quality of life.
Materials and methods: Prospective pilot study conducted in 10 patients with chronic pain treated with neural therapy between July 2017 and April 2018 in Bogotá D.C., Colombia. Three consultations were performed (one in which the intervention was initiated, and two follow-up visits every three weeks). During each consultation, the patients’ quality of life was assessed using the SF-12 scale and their NGF and BDNF serum levels were measured. Data were analyzed by means of descriptive statistics, using medians and interquartile ranges for quantitative variables, and absolute frequencies and percentages for qualitative variables.
Results: The median score on the SF-12 scale tended to improve in the first and second follow-up visits compared with the baseline score (pre-intervention), particularly during the first follow-up visit (consultation No. 1: 34.5; follow-up No. 1: 39.5, and follow-up No. 2: 38). Median NGF serum levels had a downward trend after the intervention, particularly in the first follow-up visit (157.6, 42.95, and 237.8, respectively), and in the case of BNDF, an overall downward trend was also found (29.96, 19.24 and 20.43, respectively). An improvement in quality of life related to the decrease in the serum levels of both neurotrophins was observed.
Conclusion: Neural therapy intervention reduced NGF and BDNF serum levels and improved the quality of life of the participants. Therefore, the behavior of these neurotrophins could become a biomarker for the diagnosis, treatment, and follow-up of patients with chronic pain.
Introducción. Las neurotrofinas (NT) son una familia de proteínas conformada por el factor de crecimiento nervioso (NGF), el factor neurotrófico derivado del cerebro (BDNF) y las neurotrofinas NT-3 y NT-4/5; estas proteínas tienen un papel esencial en la supervivencia, diferenciación y proliferación neuronal.
Objetivos. Analizar las variaciones de los niveles séricos del NGF y el BDNF en pacientes con dolor crónico luego de recibir terapia neural y establecer los efectos de este tipo de intervención en su calidad de vida.
Materiales y métodos. Estudio piloto prospectivo realizado en 10 pacientes con dolor crónico tratados con terapia neural entre julio de 2017 y abril de 2018 en Bogotá D.C., Colombia. Se realizaron 3 consultas (una en la que se inició la intervención y dos de control cada tres semanas) y en cada una se evaluó la calidad de vida mediante el cuestionario de salud SF-12 y se midieron los niveles séricos del NGF y el BDNF. Los datos se analizaron mediante estadística descriptiva, utilizando medianas y rangos intercuartiles para las variables cuantitativas, y frecuencias absolutas y porcentajes para las cualitativas.
Resultados. La mediana de puntaje del cuestionario SF-12 tendió a mejorar en el primer y segundo control comparada con la puntuación inicial (antes de la intervención), en particular en el primer control (consulta 1: 34.5; control 1: 39.5, y control 2: 38). La mediana de los niveles séricos del NGF tendió a disminuir luego de la intervención, en particular en el primer control (157.6, 42.95 y 62.2, respectivamente), y en el caso del BNDF, la tendencia global también fue hacia la disminución (29.96, 19.24 y 20.43, respectivamente). Se observó una mejora en la calidad de vida relacionada con la disminución de los niveles séricos de ambas neurotrofinas.
Conclusión. La intervención de terapia neural produjo una reducción en los niveles séricos del NGF y el BDNF y mejoró la calidad de vida de los participantes; por tanto, el comportamiento de estas neurotrofinas podría convertirse en un biomarcador para el diagnóstico, tratamiento y seguimiento de pacientes con dolor crónico.
Descargas
Citas
Bradshaw RA, Mobley W, Rush RA. Nerve Growth Factor and Related Substances: A Brief History and an Introduction to the International NGF Meeting Series. Int J Mol Sci. 2017;18(6):1143. https://doi.org/gbmcxr.
Blum R, Konnerth A. Neurotrophin-Mediated Rapid Signaling in the Central Nervous System: Mechanisms and Functions. Physiology (Bethesda). 2005;20:70-8. https://doi.org/fkxzmh.
Numakawa T, Odaka H, Adachi N. Actions of Brain-Derived Neurotrophic Factor and Glucocorticoid Stress in Neurogenesis. Int J Mol Sci. 2017;18(11):2312. https://doi.org/gcq2k2.
da Silva-Meirelles L, Simon D, Regner A. Neurotrauma: The Crosstalk between Neurotrophins and Inflammation in the Acutely Injured Brain. Int J Mol Sci. 2017;18(5):1082. https://doi.org/gddshg.
Shohayeb B, Diab M, Ahmed M, Ng DCH. Factors that influence adult neurogenesis as potential therapy. Transl Neurodegener. 2018;7:4. https://doi.org/gf6chs.
Brick RM, Sun AX, Tuan RS. Neurotrophically Induced Mesenchymal Progenitor Cells Derived from Induced Pluripotent Stem Cells Enhance Neuritogenesis via Neurotrophin and Cytokine Production. Stem Cells Transl Med. 2018;7(1):45-58. https://doi.org/gg7k.
Kernie SG, Parada LF. The Molecular Basis for Understanding Neurotrophins and Their Relevance to Neurologic Disease. Arch Neurol. 2000;57(5):654-7. https://doi.org/dgx9bq.
Mitre M, Mariga A, Chao MV. Neurotrophin signalling: novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 2017;131(1):13-23. https://doi.org/gg7m.
Sánchez-Sánchez J, Arévalo JC. A Review on Ubiquitination of Neurotrophin Receptors: Facts and Perspectives. Int J Mol Sci. 2017;18(3):630. https://doi.org/f9v89f.
Aydemir O, Deveci A. [BDNF Measurement in Stress-Related Mood Disorders: A Review of Clinical Studies]. Turk Psikiyatri Derg. 2009;20(4):385-91.
Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H. BDNF Function and Intracellular Signaling in Neurons. Histol Histopathol. 2010;25(2):237-58. https://doi.org/ghxmst.
Al-Qudah MA, Al-Dwairi A. Mechanisms and regulation of neurotrophin synthesis and secretion. Neurosciences (Riyadh). 2016;21(4):306-13. https://doi.org/gddsh8.
Lucini C, D’Angelo L, Cacialli P, Palladino A, de Girolamo P. BDNF, Brain, and Regeneration: Insights from Zebrafish. Int J Mol Sci. 2018;19(10):3155. https://doi.org/gfndvf.
Indo Y. NGF-dependent neurons and neurobiology of emotions and feelings: Lessons from congenital insensitivity to pain with anhidrosis. Neurosci Biobehav Rev. 2018;87:1-16. https://doi.org/gdbmm6.
Shen T, You Y, Joseph C, Mirzaei M, Klistorner A, Graham SL, et al. BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders. Aging Dis. 2018;9(3):523-36. https://doi.org/gh3t.
Sohrabji F, Lewis DK. Estrogen-BDNF Interactions: Implications for Neurodegenerative Diseases. Front Neuroendocrinol. 2006;27(4):404-14. https://doi.org/fjgz5q.
Phillips C. Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection. Neural Plast. 2017;2017:7260130. https://doi.org/gbw579.
Patel MK, Kaye AD, Urman RD. Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis. J Anaesthesiol Clin Pharmacol. 2018;34(1):111-6.
García-Cosamalón J, Del Valle ME, Calavia MG, García-Suárez O, López-Muñiz A, Otero J, et al. Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain. J. Anat. 2010;217(1):1-15. https://doi.org/czcwzb.
Beltran-Dussan EH, Urrego-Mendoza DZ. Un sistema médico denominado medicina Neuralterapéutica. In: Beltran-Dussan EH, Vega JA, editors. Medicina Neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá D.C.: Editorial Universidad Nacional de Colombia; 2013. p. 29-49.
Dosch JP, Dosch M. Manual Of Neural Therapy Acording ToHuneke. 2nd ed. New York: Thieme; 2006.
Atalay NS, Sahin F, Atalay A, Akkaya N. Comparison of efficacy of neural therapy and physical therapy in chronic low back pain. Afr J Tradit Complement Altern Med. 2013;10(3):431-5. https://doi.org/gh3v.
Katz J, Rosenbloom BN, Fashler S. Chronic Pain, Psychopathology, and DSM-5 Somatic Symptom Disorder. Can J Psychiatry. 2015;60(4):160-7. https://doi.org/gfkp3t.
Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care. 1996;34(3):220-33. https://doi.org/bnqf8d.
Huo T, Guo Y, Shenkman E, Muller K. Assessing the reliability of the short form 12 (SF-12) health survey in adults with mental health conditions: a report from the wellness incentive and navigation (WIN) study. Health Qual Life Outcomes. 2018;16(1):34. https://doi.org/gc3pzp.
White MK, Maher SM, Rizio AA, Bjorner JB. A meta-analytic review of measurement equivalence study findings of the SF-36® and SF-12® Health Surveys across electronic modes compared to paper administration. Qual Life Res. 2018;27(7):1757-67. https://doi.org/gdrrm3.
World Medical Association (WMA). WMA Declaration of Helsinki – Ethical principles for medical research involving human subjects. Fortaleza: 64th WMA General Assembly; 2013.
Colombia. Ministerio de Salud. Resolución 8430 de 1993 (octubre 4): Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Bogotá D.C.; octubre 4 de 1993.
McKelvey L, Shorten GD, O’Keeffe GW. Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J Neurochem. 2013;124(3):276-89. https://doi.org/f4hjqz.
Miller RE, Malfait AM, Block JA. Current status of nerve growth factor antibodies for the treatment of osteoarthritis pain. Clin Exp Rheumatol. 2017;35(5 Suppl 107):85-7.
Bernard SA, Chelminski PR, Ives TJ, Ranapurwala SI. Management of Pain in the United States-A Brief History and Implications for the Opioid Epidemic. Health Serv Insights. 2018;11:1178632918819440. https://doi.org/gf6gmq.
Koskela M, Bäck S, Võikar V, Richie CT, Domanskyi A, Harvey BK, et al. Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol Dis. 2017;97(Pt B):189-200. https://doi.org/f9g9m5.
Kaplan GB, Vasterling JJ Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behav Pharmacol. 2010;21(5-6):427-37. https://doi.org/crxw3n.
Pinilla-Bonilla LB. Validez y fuerza científica de los fundamentos de la terapia neural: Un estudio de la obra de Speranzky. In: Beltran-Dussan EH, Vega JA, editors. Medicina Neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá D.C.: Editorial Universidad Nacional de Colombia; 2013. p. 51-72.
Fisher L. Terapia Neural según Huneke. 3rd ed. México D.F.: Armin Reimers; 2012
Khan N, Smith MT. Neurotrophins and Neuropathic Pain: Role in Pathobiology. Molecules. 2015;20(6):10657-88. https://doi.org/f7kcgs.
Zhang H, Qian YL, Li C, Liu D, Wang L, Wang XY, et al. Brain-Derived Neurotrophic Factor in the Mesolimbic Reward Circuitry Mediates Nociception in Chronic Neuropathic Pain. Biol Psychiatry. 2017;82(8):608-18. https://doi.org/gh3x.
Liu B, Liu Y, Li N, Zhang J, Zhang X. Oxycodone regulates incision-induced activation of neurotrophic factors and receptors in an acute post-surgery pain rat model. J Pain Res. 2018;11:2663-74. https://doi.org/gh3z.
Keefe KM, Sheikh IS, Smith GM. Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. Int J Mol Sci. 2017;18(3):548. https://doi.org/gdh73v.
Tu WZ, Li SS, Jiang X, Qian XR, Yang GH, Gu PP, et al. Effect of electro-acupuncture on the BDNF-TrkB pathway in the spinal cord of CCI rats. Int J Mol Med. 2018;41(6):3307-15. https://doi.org/gh32.
Licencia
Derechos de autor 2021 Revista de la Facultad de Medicina
Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.
-
